InTrack Investment Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,169
Closed -$344K 133
2024
Q2
$344K Sell
3,169
-6
-0.2% -$707 0.24% 106
2024
Q1
$419K Sell
3,175
-1,179
-27% -$147K 0.31% 95
2023
Q4
$530K Buy
4,354
+300
+7% +$33.5K 0.4% 81
2023
Q3
$455K Buy
4,054
+599
+17% +$76.1K 0.4% 84
2023
Q2
$503K Sell
3,455
-941
-21% -$128K 0.41% 81
2023
Q1
$562K Sell
4,396
-62
-1% -$7.78K 0.52% 67
2022
Q4
$568K Buy
4,458
+295
+7% +$34.2K 0.57% 60
2022
Q3
$435K Sell
4,163
-442
-10% -$48.5K 0.48% 70
2022
Q2
$484K Sell
4,605
-315
-6% -$37.4K 0.5% 68
2022
Q1
$629K Sell
4,920
-1,015
-17% -$122K 0.51% 70
2021
Q4
$732K Buy
5,935
+1,644
+38% +$215K 0.51% 78
2021
Q3
$607K Buy
4,291
+320
+8% +$47.1K 0.44% 78
2021
Q2
$628K Sell
3,971
-592
-13% -$95.9K 0.49% 70
2021
Q1
$709K Sell
4,563
-113
-2% -$17.5K 0.65% 54
2020
Q4
$700K Buy
+4,676
New +$660K 0.7% 53

Other funds holding ZBH

InTrack Investment Management's ZBH Position: Q3 2024 in Review

InTrack Investment Management sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 3,169 shares — an estimated $344K sold.

InTrack Investment Management first reported a position in ZBH in Q4 2020 and held it in 15 quarters. The position peaked at $732K in Q4 2021. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • InTrack Investment Management reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
  • InTrack Investment Management sold 3,169 Zimmer Biomet shares in Q3 2024, an estimated $344K.
  • InTrack Investment Management first reported a position in Zimmer Biomet in Q4 2020 and held it in 15 quarters.
  • InTrack Investment Management's Zimmer Biomet position peaked at $732K in Q4 2021.
  • 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on InTrack Investment Management's 13F filing for Q3 2024, filed 10 Oct 2024.